Yousif Capital Management’s ADMA Biologics ADMA Stock Holding History

Yousif Capital Management’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$530K	Sell	63,368 -1,195	-2%	-$10.9K	0.01%	1324
2026 Q1	$582K	Sell	64,563 -1,341	-2%	-$21.2K	0.01%	1336
2025 Q4	$1.16M	Sell	65,904 -9,178	-12%	-$155K	0.01%	1005
2025 Q3	$1.1M	Sell	75,082 -16,013	-18%	-$274K	0.01%	1045
2025 Q2	$1.66M	Buy	91,095 +1,837	+2%	+$37.5K	0.02%	840
2025 Q1	$1.77M	Sell	89,258 -1,819	-2%	-$31.5K	0.02%	786
2024 Q4	$1.56M	Sell	91,077 -667	-0.7%	-$12.5K	0.02%	891
2024 Q3	$1.83M	Buy	+91,744	New	+$1.43M	0.02%	824

Other funds holding ADMA

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

Yousif Capital Management's ADMA Position: Q2 2026 in Review

Yousif Capital Management reduced its ADMA Biologics (ADMA) stake by 1.9% in Q2 2026, selling an estimated $10.9K and leaving 63,368 shares worth $530K. The position accounts for 0.01% of the portfolio, ranked #1324.

Yousif Capital Management first reported a position in ADMA in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.83M in Q3 2024. 42 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

Yousif Capital Management held 63,368 shares of ADMA Biologics worth $530K as of Q2 2026.
Yousif Capital Management sold 1,195 ADMA Biologics shares in Q2 2026, an estimated $10.9K.
ADMA Biologics made up 0.01% of Yousif Capital Management's portfolio in Q2 2026, its #1324 holding.
Yousif Capital Management first reported a position in ADMA Biologics in Q3 2024 and has held it in 8 quarters since.
Yousif Capital Management's ADMA Biologics position peaked at $1.83M in Q3 2024.
42 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.